Search
Now showing items 1-8 of 8
Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission
(Elsevier, 2021-03)
Abstract
Introduction & objectives: The independent effect of liver biochemistries as a prognostic factor in patients with COVID-19 has not been completely addressed. We aimed to evaluate the prognostic value of abnormal ...
Liver transplantation for hepatocellular carcinoma: impact of expansion criteria in a multicenter cohort study from a high waitlist mortality region
(Wiley, 2021-01)
Abstract
This study aimed to compare liver transplantation (LT) outcomes and evaluate the potential rise in numbers of LT candidates with hepatocellular carcinoma (HCC) of different allocation policies in a high waitlist ...
Assessing the impact of COVID-19 on liver cancer management (CERO-19)
(Elsevier, 2021-06)
Abstract
Background & aims: The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated ...
Recurrence of hepatocellular carcinoma after liver transplantation: Prognostic and predictive factors of survival in a Latin American cohort
(Wiley, 2021-04)
Abstract
Background & aim: Recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) has a poor prognosis, and the adjusted effect of different treatments on post-recurrence survival (PRS) has not been ...
Direct-acting antiviral treatment failure in genotype 2 hepatitis C chronic infection
(Wiley, 2021-02)
Comment J Viral Hepat
. 2021 Feb;28(2):446-447. doi: 10.1111/jvh.13433. Epub 2020 Nov 18.
Direct-acting antiviral treatment failure in genotype 2 hepatitis C chronic infection
Ezequiel Ridruejo 1 2 3, Federico Piñero 2 ...
Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study
(Wiley, 2021-12)
Abstract
Safety of regorafenib in hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) has been recently demonstrated. We aimed to assess the survival benefit of regorafenib compared with best ...
International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
(Elsevier, 2021-07)
Abstract
Background & aims: Good outcomes after liver transplantation (LT) have been reported after successfully downstaging to Milan criteria in more advanced hepatocellular carcinoma (HCC). We aimed to compare post-LT ...